voice search
Geffy Tablets

Geffy Tablets

Price:

Get Latest Price

In Stock

In Stock

Product Specifications

BrandGeffy
Active IngredientGefitinib
Strength250 mg
FormTablet
Packaging10 tablets
ManufacturerIntas Pharmaceuticals
UsageTreats lung and liver cancer; used after docetaxel failure.
FeaturesCancer treatment, Tyrosine inhibitor, Lung cancer, Liver cancer, 250mg strength

Product Overview

Key Features

Geffy 250 Anti Cancer Tablets are basically special types of drugs called tyrosine kinase inhibitors (TKI). This medicine inhibits the action of kinases that are the proteins in found the body, responsible for regulating the growth and division of cells. It is also known as a cancer growth inhibitor and works by blocking and inhibiting the protein from sending signals to the cancer cells that make them grow and divide.

Company Details

Ace Golden International is a partnership firm registered under Indian Partnership Act 1932. The company carries over hundreds of pharmaceutical products, that fall under more than 20 categories. We are one of the largest Manufacturer, Importer, Wholesaler/Distributor, Trader & Supplier from Mumbai, Maharashtra (India). We are one complete source for health care supplies, which include Oncology Medicines, Pain Relief Medicines, Cancer Medicine, Skin Care Medicines, Hair Care Medicine, General Health Care Medicines, Blood Pressure Tablets, and many more. @page { margin: 0.79in } p { margin-bottom: 0.1in; line-height: 120% }

Business Type

Exporter, Manufacturer, Distributor, Supplier, Trading Company

Employee Count

30

Establishment

2001

Working Days

Monday To Sunday

Related Products

Explore Related Categories

More Products From This Seller

Seller Details

Mumbai, Maharashtra

Seller Inquiry

Accepts only Foreign inquiries

Partner

Mr. Afzal Maqsood Shaikh

Address

GALA NO A/12, ARISTOCRATE LAJYA COMPOUND, MOGRA VILLAGE, ANDHERI EAST, Mumbai, Maharashtra, 400069, India

anti cancer medicine in Mumbai

Report incorrect details

Compare With Similar Products

Buyer Feedback

4